On the basis of in vitro and in vivo investigations trans-resveratrol (RV) is a natural, concentration-dependent formaldehyde (HCHO) mobilizer, scavenger, capture and carrier molecule. The capturing and mobilization of HCHO from a given biological unit (e.g. tissue) with RV (first step) generates a chemopreventive effect. The reaction products between endogenous HCHO and RV (second step) may exert killing/inhibiting effects on pathogens and/or cancer cells. These two steps result in the double effect of RV. From the model reaction mixture of RV and HCHO in diluted formalin solution, different reaction products were detected, separated and identified. Similar reactions can be observed between RV and endogenous HCHO in plant and animal tissues as well. Capturing the HCHO molecules in model experiments with HCHO-capture molecules (in vitro conditions) the antibacterial activity of RV decreased substantially. The in vitro investigations were extended to in vivo conditions. The discovery of a quadruple immune response of plants to pathogens resulting from pretreatment with RV opens new horizons in the confirmation of the diverse beneficial effects of RV.
RenaudS., de LorgerilM. (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet, 339, 1523–1526.
2.
HaoH.D., HeL.L.R. (2004) Mechanisms of cardiovascular protection by resveratrol. Journal of Medicinal Food, 7, 290–298.
3.
LangcakeP., PryceR.J. (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiological Plant Pathology, 9, 77–86.
4.
SiemannE.H., CreasyL.L. (1992) Concentration of phytoalexin resveratrol in wine. American Journal of Enology and Viticulture, 43, 49–52; (b) Guerrero RF, García-Parrilla MC, Belén Puertas B, Cantos-Villar E. (2009) Wine, resveratrol and health: a review, Natural Product Communications, 4, 635-658; (c) Chillemi R, Sciuto S, Spatafora C, Tringali C. (2007) Antitumor properties of stilbene-based resveratrol analogues: Recent results, Natural Product Communications, 2, 499-513.
5.
CreasyL.L., CoffeeM. (1988) Phytoalexin production potential of grape berries. Journal of the American Society for Horticultural Science, 113, 230–234; (b) Trela B, Waterhouse A. (1996) Resveratrol: isomeric molar absorptivities and stability. Journal of Agricultural and Food Chemistry, 44, 1253-1257; (c) Fremont L. (2000) Biological effects of resveratrol. Life Sciences, 66, 663-673; (d) Pervaiz S. (2003) Resveratrol: from grapevines to mammalian biology. Faseb Journal, 17, 1975-1985.
6.
HaoH.D., HeL.R. (2004) Mechanisms of cardiovascular protection by resveratrol. Journal of Medicinal Food, 7, 290–298.
7.
JangM., CaiL., UdeaniG.O., SlowingK.V., ThomasCf, BeecherC.W., FongH.H., FarnsworthN.R., KinghornA.D., MehtaR.G., MoonR.C., PezzutoJ.M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218–220; (b) Kundu JK, Surh Y-J. (2004) Molecular basis of chemoprevention by resveratrol: NF-kB and AP-1 as potential targets. Mutation Research, 555, 65-80; (c) Szende B, Tyihák E, Király-Véghely Zs. (2000) Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Experimental and Molecular Medicine, 32, 88-92.
8.
AggarwalB.B., BhardwajA., AggarwalR.S., SeeramN.P., ShishodiaS., TakadaY. (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Research, 24, 2783–2840.
9.
SaikoPh, SzakmaryA., JaegerW., SzekeresT. (2008) Resveratrol and its analogs: Defence against cancer, coronary disease and neurodegenerative maladies or just a fad?Mutation Research, 658, 68–94.
10.
BertelliA.A., GiovanniniL., StradiR., UrienS., TillementJ.P., BertelliA. (1998) Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs under Experimental and Clinical Research, 24, 51–55.
11.
AumontV., KrisaS., BattagliaE., NetterP., RichardT., MerillonJ.M., MagdalouJ., SabolovicN. (2001) Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Archives of Biochemistry and Biophysics, 393, 281–289.
12.
De SantiC., PietrabissaA., SpisniR., MoscaF., PacificiG.M. (2000) Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica, 30, 609–617.
13.
SgambatoA., ArditoR., FaragliaB., BoninsegnaA., WolfFi, CittadiniA. (2001) Resveratrol, a natural phenolic compound inhibits cell proliferation and prevents oxidative DNA damage. Mutation Research, 496, 171–180.
14.
BoyceA., DoehmerJ., GooderhamN.J. (2004) Phytoalexin resveratrol attenuates the mutagenicity of the heterocyclic amines 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Journal of Chromatography B, 802, 217–223; (b) Feng Y-H, Zhou W-L, Wu Q-Li, Li X-Y, Zhao W-M, Zou J-P. (2002) Low dose of resveratrol enhanced immune response of mice. Acta Pharmacologica Sinica, 23, 893-897; (c) Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. (2001) Effect of resveratrol on human immune cell function. Life Sciences, 70, 81-96; (d) Barriello A, Cucciolla V, Della Ragiona F, Galletti P. (2010) Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutrition Metabolism and Cardiovascular Diseases, 20, 618-625.
15.
JimenezJB, OreaJM, MonteroC, UrenaAG, NavasE, SlowingK, Gomez-SerranillosMP, CarreteroF, De MartinisD. (2005) Resveratrol treatment controls microbial flora, prolongs shelf life, and preserves nutritional quality of fruit. Journal of Agricultural and Food Chemistry, 53, 1526–1530.
16.
PalamaraAT, NencioniL, AquilanoK, DeChiaraG, HernandezL, CozzolineF, CirioloMR, GaraciE. (2005) Inhibition of influenza A virus replication by resveratrol. The Journal of Infectious Diseases, 191, 1719–1729.
17.
CampagnaM, RivasC. (2010) Antiviral activity of resveratrol. Biochemical Society Transactions, 38, 50–53
18.
TyihákE, KátayG, Király-VéghelyZ, NémethZ, AlbertL, SzendeB. (2003) Vitis vinifera as a medicinal plant. Acta Horticulturae, 597, 159–165; (b) Tyihák E, Király-Véghely Zs. (2008) Interaction of trans-resveratrol with endogenous formaldehyde as one basis of its diverse beneficial biological effects. Bulletin de l'OIV, 81, 65-74.
19.
CheongH, RyuSY, KimKM. (1999) Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Medica, 65, 266–268.
20.
MarambaudP, ZhaoH, DaviesP. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-b-peptides. Journal of Biological Chemistry, 280, 37377–37382.
21.
BereswillS, MunozM, FischerA, PlickertR, HaagL-M, OttoB, KühkAA, LoddenkemperC, GöbelUB, HeimesaatMM. (2010) Anti-inflammatory effects of resveratrol, curcumin, and simvastatin in acute small intestinal inflammation. PLoS One, 5, e15090.
22.
InghamJL. (1976) 3,5,4′-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogea). Phytochemistry, 15, 1791–1793.
23.
MahadyGB, PendlandSL. (2000) Resveratrol inhibits the growth of Helicobacter pylori in vitro. American Journal of Gastroenterology, 95, 1849–1852; (b) Alkhalaf M, El-Mowafy A, Renno W, Rachid O, Ali A, Al-Attyiah R. (2008) Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Archives of Medical Research, 39, 162-168; (c) Gautam SC. (2000) Resveratrol selectively inhibits leukemia cells: a perspective agent for ex vivo bone marrow purging. Cancer Letters, 25, 639-645; (d) Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. (2001) Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. International Journal of Molecular Medicine, 8, 3-17.
24.
WaddingtonE, PuddeyIB, CroftKD. (2004) Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. American Journal of Clinical Nutrition, 79, 54–61.
25.
WangLX, HerediaA, SongH, ZhangZ, YuB, DavicC, RedfieldR. (2004) Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis and anti-HIV activity. Journal of Pharmaceutical Sciences, 93, 2448–2457.
26.
HashinoJ, ParkEJ, KondratyukTP, MarlerL, PezzutoJM, van BreemenRB, MoS, LiY, CushmanM. (2010) Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. Journal of Medicinal Chemistry, 53, 5033–5043.
27.
Király-VéghelyZs, TyihákE, AlbertL, NémethZsI, KátayGy. (1998) Identification and measurement of resveratrol and formaldehyde in parts of white and blue grape berries. Acta Biologica Hungarica, 49, 281–289.
28.
TyihákE, MincsovicsE, KátayGy, Király-VéghelyZs, MóriczÁM, OttGP. (2008) BioArena: An unlimited possibility of biochemical interactions in the adsorbent layer after chromatographic separation. Journal of Planar Chromatography, 21, 15–20.
29.
TyihákE, AlbertL, NémethZsI, KátayGy, Király-VéghelyZs, SzendeB. (1998) Formaldehyde cycle and the natural formaldehyde generators and capturers. Acta Biologica Hungarica, 49, 225–239; (b) Tyihák E, Trézl L, Szende B. (1998) Formaldehyde cycle and the phases of stress syndrome. Annals of the New York Academy of Sciences, 851, 259-270; (c) Duthie SJ. (2011) Epigenetic modifications and human pathologies: cancer and CVD. Proceedings of the Nutrition Society, 70, 47-56.
30.
HusztiS, TyihákE. (1986) Formation of formaldehyde from S-adenosyl-L[methyl-3H]methionine during enzymic transmethylation of histamine. FEBS Letters, 209, 362–366; (b) Tyihák E, Móricz ÁM, Ott PG, Kátay Gy, Király-Véghely Zs. (2005) The potential of BioArena in the study of formaldehydome. Journal of Planar Chromatography, 18, 67-72; (c) Blunden G, Carpenter BG, Adrian-Romero M, Yang M-H, Tyihák E. (1998) Formaldehyde in plant kingdom. Acta Biologica Hungarica, 49, 239-246; (d) Adrian-Romero M, Blunden G, Carpenter BG, Tyihák E. (1999) HPLC quantification of formaldehyde as formaldemethone in plants and plant-like organisms. Chromatographia, 50, 160-167.
TongZ, ZhangJ, LuoW, WangW, LiF, LiH, LuoH, LuJ, ZhouJ, WanY, HeR. (2011) Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiology of Aging, 32, 31–41.
33.
TyihákE., MincsovicsE. (2001) in Planar Chromatography –A Retrospective View for the Third Millennium, NyiredySz. (Ed.) Springer, Budapest, 193–213; (b) Trézl L, Pipek J. (1988) Formation of excited formaldehyde in model reactions simulating real biological systems. Journal of Molecular Structure –Theochemistry, 170, 213-223; (c) Tyihák E, Rozsnyay S, Sárdi É, Gullner G, Trézl L, Gáborjányi R. (1994) Possibility of formation of excited formaldehyde and singlet oxygen in biotic and abiotic stress situations. Acta Biologica Hungarica, 45, 3-10; (d) Wentworth AD, Jones LH, Wentworth P, Jr., Janda KD, Lerner RA. (2000) Antibodies have the intrinsic capacity to destroy antigens. Proceedings of the National Academy of Sciences USA, 97, 10930-10935.
34.
WentworthP.Jr., WentworthA.D., ZhuX., WilsonI.A., JandaK.D., EschenmoserA., LernerR.A. (2003) Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens. Proceedings of the National Academy of Sciences USA, 100, 1490–1493; (b) Tyihák E, Móricz ÁM, Ott PG. (2008) Use of the BioArena system for indirect detection of endogenous ozone in spots after TLC or OPLC separation. Journal of Planar Chromatography, 21, 77-82; (c) Móricz ÁM, Adányi N, Horváth E, Ott PG, Tyihák E. (2008) Applicability of the BioArena system to investigation of the mechanisms of biological effects. Journal of Planar Chromatography, 21, 417-422.; (d) Tyihák E, Steiner U, Schönbeck F. (1989) Induction of disease resistance by Nε-trimethyl-L-lysine in bean plants against Uromyces phaseoli. Journal of Phytopathology, 126, 253-256.
35.
TyihákE. (2006) Double immune response of plants to pathogens and its biochemical basis. In Floriculture, Ornamental and Plant Biotechnology, Advances and Topical Issues.Teixeira da SilvaJ.A., (ed.) Vol. 3, Global Science Books, London, UK, 180–188.
36.
TyihákE., MincsovicsE. (2010) Forced flow planar liquid chromatographic techniques (After twenty-two years). Journal of Planar Chromatography, 23, 382–395; (b) Tyihák E, Ott P, Móricz ÁM, Kátay Gy, Király-Véghely Zs. (2004) Antibiosis, antibiotics and formaldehyde cycle: the unique importance of planar chromatographic techniques to progress in these fields. Journal of Planar Chromatography, 17, 84-88; (c) Tyihák E, Móricz ÁM, Ott PG. (2008) Biodetection and determination of biological activity of natural compounds. In Thin Layer Chromatography in Phytochemistry, Waksmundzka-Hajnos M, Sherma J, Kowalska T. (Eds), CRC Press, Taylor & Francis Group, Boca Raton. 193-213.
37.
MóriczÁ, OttaK.H., OttP., TyihákE. (2003) Separation and detection of aflatoxins using overpressured-layer chromatography and bioautography. Journal of Planar Chromatography, 16, 417–420; (b) Mincsovics E, Ferenczi-Fodor K, Tyihák E. (2003) Overpressured layer chromatography. In Handbook of TLC, Sherma J, Fried B. (Eds), 3rd ed., New York, Marcel Dekker, CH 7, 175-205; (c) Albert L, Németh Zs, Barna T, Varga Sz, Tyihák E. (1998) Measurement of endogenous formaldehyde in the early development stages of European Turkey oak (Quercus cerris L.). Phytochemical Analysis, 9, 227-231.
